BDBM506020 US11066414, Compound 669::bi(cyclopropan)]-1-yl)- 1H-1,2,3-triazol-4-yl)(6- fluoro-2-methylpyridin-3- yl)methyl)amino)-8- chloro-4-(((R)-3,3- dimethyltetrahydro-2H-pyran- 4-yl)amino)quinoline-3-carbonitrile

SMILES Cc1nc(F)ccc1[C@H](Nc1cc(Cl)c2ncc(C#N)c(N[C@@H]3CCOCC3(C)C)c2c1)C1=CN(NN1)C1(CC1)C1CC1

InChI Key InChIKey=XLADEWMZCVJLAE-VIZCGCQYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 506020   

TargetEpidermal growth factor receptor(Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM506020(US11066414, Compound 669 | bi(cyclopropan)]-1-yl)-...)
Affinity DataIC50:  1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent